VT0367 – Non-surgical induction of ptosis: indications, spectrum of treatment, drugs used and the techniques
VT0367 – Non-surgical induction of ptosis: indications, spectrum of treatment, drugs used and the techniques
Share this post
Dr. Priyanka v Walvekar
, Dr. ABHIMANYU SHARMA, Dr.TARJANI DAVE
Abstract
While much is known about the management of ptosis, certain eyelid and ocular surface conditions need the reverse i.e. induction of ptosis. Thyroid eye disease (TED) is frequently associated with eyelid retraction. Managing eyelid retraction during the active phase becomes imperative to treat and prevent exposure keratopathy. As eyelid height is variable during the active phase of TED, concerned patients often look for an aesthetic quick-fix. Similarly, in long standing facial palsy due to incomplete eyelid closure exposure keratopathy ensues. In these clinical scenarios, inducing ptosis reduces the palpebral fissure height and corneal protection can be achieved as a temporary remedy. Medical options such as botulinum toxin and triamcinolone acetonide injections are broadly preferred. Botulinum toxin induced chemodenervation of the levator muscle is a quick and easy procedure for the induction of temporary ptosis thereby avoiding a surgical correction and subsequent eyelid scarring.
Leave a Comment